Revisor Wealth Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$357K Sell
3,899
-70
-2% -$6.13K 0.09% 260
2026
Q1
$339K Sell
3,969
-211
-5% -$18.8K 0.09% 230
2025
Q4
$361K Sell
4,180
-172
-4% -$13.5K 0.1% 213
2025
Q3
$341K Sell
4,352
-558
-11% -$47.6K 0.12% 191
2025
Q2
$445K Buy
4,910
+157
+3% +$14.3K 0.16% 151
2025
Q1
$445K Buy
4,753
+2,121
+81% +$190K 0.2% 130
2024
Q4
$238K Sell
2,632
-1,131
-30% -$108K 0.22% 99
2024
Q3
$391K Sell
3,763
-73
-2% -$7.44K 0.24% 100
2024
Q2
$372K Sell
3,836
-3,549
-48% -$327K 0.26% 84
2024
Q1
$627K Buy
7,385
+3,750
+103% +$318K 0.28% 87
2023
Q4
$290K Sell
3,635
-1,093
-23% -$82.2K 0.33% 77
2023
Q3
$336K Buy
4,728
+929
+24% +$69.5K 0.29% 91
2023
Q2
$293K Sell
3,799
-112
-3% -$8.67K 0.26% 107
2023
Q1
$294K Buy
+3,911
New +$291K 0.27% 103

Other funds holding CL

Revisor Wealth Management's CL Position: Q2 2026 in Review

Revisor Wealth Management reduced its Colgate-Palmolive (CL) stake by 1.8% in Q2 2026, selling an estimated $6.13K and leaving 3,899 shares worth $357K. The position accounts for 0.09% of the portfolio, ranked #260.

Revisor Wealth Management first reported a position in CL in Q1 2023 and has held it in 14 quarters since. The position peaked at $627K in Q1 2024. 2,016 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Revisor Wealth Management held 3,899 shares of Colgate-Palmolive worth $357K as of Q2 2026.
  • Revisor Wealth Management sold 70 Colgate-Palmolive shares in Q2 2026, an estimated $6.13K.
  • Colgate-Palmolive made up 0.09% of Revisor Wealth Management's portfolio in Q2 2026, its #260 holding.
  • Revisor Wealth Management first reported a position in Colgate-Palmolive in Q1 2023 and has held it in 14 quarters since.
  • Revisor Wealth Management's Colgate-Palmolive position peaked at $627K in Q1 2024.
  • 2,016 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Revisor Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.